A better understanding of the S1P role in the regulation of macrophage production and polarization in MM could lead to the development of new therapies which may target TAMs by reprogramming them toward an M1 phenotype and activation of their antitumor response. The gene discussed is MBTPS1; the disease is Miyoshi myopathy.